Lifestyle Delivery Systems Inc. Announces CSPA Group, Inc. and Core Isogenetics, Inc. Shareholder Facility Experience Tour at the Annual General Meeting
Lifestyle Delivery Systems Inc. (LDS.CN), (LDSYF), (Frankfurt: LD6, WKN: A14XHT) (“LDS” or the “Company”) announces its wholly-owned subsidiaries, CSPA Group, Inc. and Core Isogenetics, Inc., will hold a shareholder facility tour for the Company’s shareholders on April 25, 2019.
LDS announces that this year’s annual general meeting of Lifestyle Delivery Systems Inc.’s shareholders (“AGM”) will be held on April 25, 2019. With a multitude of milestones to share this year it would be impossible to convey the totality of the LDS vision in words alone. To the benefit of the Company’s shareholders, and in an effort to help them understand all aspects of the Company, this year the AGM is being held in Adelanto, California. It will be a unique AGM in its unconventional level of access for the Company’s shareholders to see their investment first hand. The reason for choosing this location was to allow LDS’ shareholders the opportunity to visit the facility and to have a greater understanding of the Company’s vision and the significance of the accomplishments that have been achieved over the last year. This year’s AGM will also allow shareholders to meet the key members of the Company’s operations and development teams, and hear first-hand the accomplishments and strategies of the only truly vertically integrated cannabis company. The LDS team in Adelanto is excited to meet its shareholders and share the results of five years of development and innovation.
Brad Eckenweiler, CEO of LDS, stated, “This AGM venue is extremely convenient to our current production facility and the new site of the Highway 395 Dispensary. Those shareholders able to attend will receive an unparalleled presentation of the LDS vision as well as an in-depth view of the Californiacannabis market.”
Shareholders intending on participating in the total LDS experience tour before the AGM should RSVP to reserve their spot at investor.relations@lifestyledeliverysystem.com, or agm@lifestyledeliverysystem.com on or before April 12, 2019.
The Company will continue to update the market on all of the results of the AGM.
About Lifestyle Delivery Systems Inc.
Lifestyle Delivery Systems Inc. is a technology company that licenses its technology to a state-of-the-art production and packaging facility located in Southern California. The Company’s technology produces infused strips (similar to breath strips) that are not only a safer, healthier option to any other form of delivery but also allows for inclusion of a wide spectrum of ingredients from over the counter medications to homeopathic, nutraceutical, vitamins and supplements. The technology provides a new way to accurately meter the dosage and assure the purity of selected product. From start to finish, the production process, based on the Company’s technology, tests for quality and composition of all the ingredients used in each and every strip which results in a delivery system that is safe, consistent and effective.
Lifestyle Delivery Systems Inc.
Brad Eckenweiler
CEO & Director
FOR MORE INFORMATION, PLEASE CONTACT:
information@lifestyledeliverysystems.com
Cautionary Disclaimer Statement:
The Canadian Securities Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this news release.
Information set forth in this news release contains forward-looking statements that are based on assumptions as of the date of this news release. These statements reflect management’s current estimates, beliefs, intentions and expectations. They are not guarantees of future performance. The Company cautions that all forward looking statements are inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond the Company’s control. Such factors include, among other things: risks and uncertainties relating to the Company’s limited operating history and the need to comply with environmental and governmental regulations. In addition, marijuana remains a Schedule I drug under the United States Controlled Substances Act of 1970. Although Congress has prohibited the US Justice Department from spending federal funds to interfere with the implementation of state medical marijuana laws, this prohibition must be renewed each year to remain in effect. Accordingly, actual and future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward looking information. Except as required under applicable securities legislation, The Company undertakes no obligation to publicly update or revise forward-looking information.
MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
